Definition and epidemiology
Albinism refers to a heterogeneous group of inherited disorders of melanin synthesis that result in reduced or absent pigmentation of the skin, hair, and eyes. The two broad categories are:
- Oculocutaneous albinism (OCA): affects skin, hair, and eyes (types OCA1-OCA7, with OCA1 and OCA2 most studied)
- Ocular albinism (OA): primarily affects the eyes with little to no visible skin/hair change (X-linked, GPR143 gene)
Albinism also occurs as a feature of rarer multisystem syndromes, including Hermansky-Pudlak syndrome (albinism plus bleeding diathesis and pulmonary fibrosis) and Chediak-Higashi syndrome (albinism plus recurrent infections and giant cytoplasmic granules).
Global prevalence of OCA is approximately 1 in 17,000-20,000, though it is markedly higher in parts of sub-Saharan Africa (as high as 1 in 1,000-5,000 in some populations). There is no sex predilection for autosomal recessive forms; ocular albinism, being X-linked, is more common and more severe in males.
- Albinism = defect in melanin synthesis/trafficking, not absence of melanocytes
- OCA is autosomal recessive; ocular albinism is X-linked (GPR143)
- Nystagmus and foveal hypoplasia occur even with mild skin involvement — eyes are always affected
- Optic chiasm misrouting is a hallmark finding, detectable by VEP
- OCA1A = no tyrosinase activity = no pigment ever; OCA1B has partial activity
- Iris transillumination defect is a classic exam finding
- Hermansky-Pudlak = albinism + bleeding diathesis + pulmonary fibrosis
- Chediak-Higashi = albinism + recurrent infections + giant granules in leukocytes
Etiology and risk factors
Albinism is caused by mutations in genes encoding proteins involved in melanin synthesis, melanosome formation, or melanosome trafficking within melanocytes.
- OCA1: mutations in TYR (tyrosinase enzyme) — OCA1A (no enzyme activity, no pigment ever develops) vs OCA1B (partial activity, some pigment accumulates with age)
- OCA2: mutations in OCA2 gene (P protein), most common form worldwide, especially in African populations
- OCA3: mutations in TYRP1, more common in African populations, often reddish-bronze skin/hair
- OCA4: mutations in SLC45A2
- Ocular albinism: X-linked mutation in GPR143
Inheritance is autosomal recessive for all OCA subtypes; ocular albinism is X-linked recessive. The key risk factor is a positive family history or parental consanguinity, which increases the likelihood of two carriers producing an affected child.
Pathophysiology
Melanin is produced by melanocytes within specialized organelles called melanosomes and is normally transferred to keratinocytes (skin/hair) and retinal pigment epithelium (eyes). In albinism, mutations impair tyrosinase activity or melanosome maturation/trafficking, so melanin production is reduced or absent despite a normal or even increased number of melanocytes.
Melanin plays a critical role in normal development of the visual system during gestation. Its absence disrupts:
- Foveal development, leading to foveal hypoplasia and reduced visual acuity
- Optic nerve routing, causing an abnormally high proportion of nerve fibers from each retina to cross at the chiasm (misrouting), which impairs binocular vision and stereopsis
- Iris and choroid pigmentation, allowing light to pass through the iris (transillumination) and causing photophobia
Skin and hair findings result directly from reduced melanin deposition, which also removes the natural photoprotection melanin provides against ultraviolet radiation.
Clinical features
Skin and hair
- Pale, translucent skin that burns easily and tans poorly
- White, pale yellow, or light brown hair (varies by subtype and age; some darken slightly over time)
- Increased risk of actinic damage, solar lentigines, and skin cancer with sun exposure
Eyes (present in essentially all forms)
- Nystagmus (usually horizontal, pendular), often the presenting sign in infancy
- Reduced visual acuity, typically 20/60 to 20/400, due to foveal hypoplasia
- Photophobia
- Iris transillumination defects (light passes through the iris on exam)
- Strabismus and reduced stereopsis from chiasmal misrouting
- Refractive errors (myopia, hyperopia, or astigmatism)
Syndromic clues
- Easy bruising/bleeding, recurrent epistaxis in Hermansky-Pudlak syndrome
- Recurrent pyogenic infections, partial albinism with silvery hair in Chediak-Higashi syndrome
Diagnosis
Diagnosis is primarily clinical, based on characteristic skin, hair, and especially ocular findings, since ocular abnormalities are present even in mild cutaneous forms.
- Full ophthalmologic exam: looking for nystagmus, iris transillumination, foveal hypoplasia, and reduced acuity
- Visual evoked potentials (VEP): can confirm optic chiasm misrouting (asymmetric response from each eye) and is useful when skin findings are subtle
- Genetic testing: confirms the specific gene/subtype (TYR, OCA2, TYRP1, SLC45A2, GPR143) and is helpful for prognosis, counseling, and ruling out syndromic forms
- Hair bulb incubation test (historical): assesses tyrosinase activity in vitro, largely replaced by genetic testing
- Additional work-up if syndromic features present: bleeding time/platelet function studies (Hermansky-Pudlak), CBC with peripheral smear looking for giant granules in leukocytes (Chediak-Higashi)
Prenatal diagnosis and carrier testing are available via molecular genetic testing when a familial mutation is known.
Differential diagnosis
| Condition | Distinguishing feature |
|---|---|
| Vitiligo | Acquired, patchy depigmentation; normal eyes; autoimmune |
| Piebaldism | Patchy congenital depigmentation (white forelock); normal eyes |
| Waardenburg syndrome | Pigment changes plus sensorineural hearing loss, dystopia canthorum |
| Phenylketonuria | Fair skin/hair from reduced melanin due to hyperphenylalaninemia; intellectual disability if untreated |
| Hermansky-Pudlak syndrome | OCA plus bleeding diathesis, pulmonary fibrosis |
| Chediak-Higashi syndrome | OCA plus recurrent infections, giant granules in leukocytes |
| Isolated congenital nystagmus | Nystagmus without hypopigmentation or iris transillumination |
Management
There is no treatment that restores melanin production; management is supportive and focused on vision and skin protection.
Ocular care
- Correction of refractive errors with glasses or contact lenses
- Low-vision aids (magnifiers, large print, assistive technology) for school/work
- Tinted lenses or sunglasses to reduce photophobia
- Surgical options (e.g., for significant strabismus) are considered on a case-by-case basis
Skin care
- Strict sun protection: broad-spectrum sunscreen, protective clothing, hats, sun avoidance during peak hours
- Regular dermatologic skin cancer screening given lifelong UV vulnerability
Psychosocial and genetic support
- Genetic counseling for patients and families regarding recurrence risk (25% for each pregnancy in autosomal recessive forms)
- Educational support given the visual impairment, often requiring accommodations in school
- Screening and management of syndromic complications when present (e.g., pulmonary function monitoring in Hermansky-Pudlak syndrome, infection prophylaxis in Chediak-Higashi syndrome)
There is no FDA- or EMA-approved pharmacologic therapy that restores pigmentation in albinism; research into gene-targeted and nitisinone-based approaches for specific OCA subtypes is ongoing but not yet standard of care.
Complications and prognosis
- Skin cancer risk: basal cell carcinoma, squamous cell carcinoma, and (less commonly) melanoma due to lifelong UV vulnerability, particularly significant in regions with high sun exposure and limited access to sun protection
- Permanent visual impairment: acuity typically remains stable but reduced throughout life; it does not usually progressively worsen
- Social and psychological impact: visual disability and appearance-related stigma, which can be severe in some regions and cultures
- Syndromic forms carry additional morbidity/mortality risk: Hermansky-Pudlak syndrome patients may develop pulmonary fibrosis and bleeding complications; Chediak-Higashi syndrome has an accelerated phase resembling lymphoma that is often fatal without hematopoietic stem cell transplantation
Overall, life expectancy in isolated OCA/OA is normal; prognosis is determined mainly by consistent sun protection and vision rehabilitation rather than by the pigment defect itself.
Think 'TOP-S' for albinism eye findings: Transillumination of iris, Optic misrouting, Photophobia, Strabismus/nystagmus — eyes are always involved regardless of skin color.
Practice questions
1. A 6-month-old infant is brought in because the parents noticed the baby's eyes move back and forth constantly. The infant has very pale skin and white hair compared to both parents, who have normal pigmentation. Ophthalmologic exam reveals horizontal nystagmus and light passing through the iris on transillumination. Which of the following best explains the ocular findings in this infant?
2. A 4-year-old boy with oculocutaneous albinism presents with recurrent severe sinopulmonary infections and easy bruising. Peripheral blood smear shows giant cytoplasmic granules in neutrophils. Which condition is most consistent with this presentation?
3. A 25-year-old man with albinism asks about his risk of skin cancer. He works outdoors and rarely uses sunscreen. Which of the following is the most appropriate counseling point regarding his long-term risk?
Frequently asked questions
What causes albinism?
Albinism is caused by inherited mutations in genes that control melanin production or melanosome trafficking in melanocytes, most commonly TYR, OCA2, TYRP1, or SLC45A2 for oculocutaneous forms, or GPR143 for X-linked ocular albinism. Most forms are autosomal recessive, meaning both parents must carry a mutated copy of the gene for a child to be affected.
What are the first symptoms of albinism?
The earliest and most consistent sign is nystagmus (involuntary eye movements), often noticed in infancy along with pale skin and hair compared to family members. Photophobia and poor visual tracking are also commonly observed early, since the eyes are affected in nearly every form of albinism even when skin pigmentation loss is mild.
How is albinism diagnosed?
Albinism is diagnosed clinically through a combination of skin and hair examination plus a detailed eye exam looking for nystagmus, iris transillumination, and foveal hypoplasia. Visual evoked potentials can confirm optic nerve misrouting, and genetic testing identifies the specific gene mutation to confirm the subtype and guide counseling.
Is albinism curable?
No, albinism is not curable because it stems from a permanent genetic defect in melanin production. Management instead focuses on protecting the skin from UV damage, correcting vision problems, and providing low-vision support; research into gene therapy and pharmacologic approaches is ongoing but not yet part of standard care.
Albinism vs vitiligo — what is the difference?
Albinism is an inherited genetic disorder present from birth that affects melanin production throughout the body, including the eyes, and causes nystagmus and reduced vision. Vitiligo is an acquired autoimmune condition that destroys melanocytes in patchy areas of skin later in life, without affecting the eyes or causing the characteristic nystagmus seen in albinism.
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: E70.3
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.